Skip to main content
. 2016 Aug 25;8(29):46834–46845. doi: 10.18632/oncotarget.11603

Figure 3.

Figure 3

(A) PLS-DA score plot for discriminating early and late EOC recurrence; (B) Validation plot for discriminating early and late recurrent EOC patients with 200 permutations; (C) PLS-DA score plot for discriminating early and non-EOC recurrence; (D) Validation plot for discriminating early and non-EOC recurrence. ER: early recurrence; LR: late recurrence; NR: non-recurrence.